Dual-specificity phosphatase DUSP1 protects overactivation of hypoxia-inducible factor 1 through inactivating ERK MAPK

被引:59
作者
Liu, CJ
Shi, YQ
Du, YL
Ning, XX
Liu, N
Huang, DW
Liang, J
Xue, Y
Fan, DM [1 ]
机构
[1] Fourth Mil Med Univ, State Key Lab Canc Biol, Xijing Hosp, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Inst Digest Dis, Xijing Hosp, Xian 710032, Peoples R China
基金
中国国家自然科学基金;
关键词
hypoxia; MKP-1; HIF-1; MAPK; phosphorylation; transactivation;
D O I
10.1016/j.yexcr.2005.06.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypoxia-inducible factor 1 (HIF-1) plays a critical role in controlling oxygen delivery and metabolic adaptation to hypoxic conditions in hypoxic tumor cells. HIF-1 activation is initiated by several factors including mitogen-activated protein kinase (MAPK) superfamily. We have previously reported that mitogen-activated protein kinase phosphatase DUSP1 (MK-P-1) was implicated in the negative regulation of HIF-1 alpha subunit phosphorylation and HIF-1 activity. However, the molecular basis by which MKP-1 influences HIF-1 activity is not clarified. In this paper, we show that hypoxia transcriptionally induces MKP-1 expression in a time-dependent manner. Meanwhile, hypoxia also activates extracellular signal-regulated kinase (ERK) whose activity is enhanced or reduced by MKP-1 suppression or MKP-1 overexpression, respectively. We also show that suppression of MKP-1 expression facilitates the interaction between HIF-1 alpha subunit and p300, a co-activator of HIF-1. Moreover, MKP-1 suppression leads to enhanced HIF-1 activity, which can be counteracted by PD98059, an ERK kinase inhibitor. Taken together, the results presented here suggest that hypoxia-induced MKP-1 protects overactivation of HIF-1 activation through inhibiting ERK kinase activity. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:410 / 418
页数:9
相关论文
共 58 条
[1]  
ALESSI DR, 1993, ONCOGENE, V8, P2015
[2]   INACTIVATION OF P42 MAP KINASE BY PROTEIN PHOSPHATASE 2A AND A PROTEIN-TYROSINE-PHOSPHATASE, BUT NOT CL100, IN VARIOUS CELL-LINES [J].
ALESSI, DR ;
GOMEZ, N ;
MOORHEAD, C ;
LEWIS, T ;
KEYSE, SM ;
COHEN, P .
CURRENT BIOLOGY, 1995, 5 (03) :283-295
[3]   REQUIREMENT FOR INTEGRATION OF SIGNALS FROM 2 DISTINCT PHOSPHORYLATION PATHWAYS FOR ACTIVATION OF MAP KINASE [J].
ANDERSON, NG ;
MALLER, JL ;
TONKS, NK ;
STURGILL, TW .
NATURE, 1990, 343 (6259) :651-653
[4]   An essential role for p300/CBP in the cellular response to hypoxia [J].
Arany, Z ;
Huang, LE ;
Eckner, R ;
Bhattacharya, S ;
Jiang, C ;
Goldberg, MA ;
Bunn, HF ;
Livingston, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (23) :12969-12973
[5]   Brain genomic response following hypoxia and re-oxygenation in the neonatal rat - Identification of genes that might contribute to hypoxia-induced ischemic tolerance [J].
Bernaudin, M ;
Tang, Y ;
Reilly, M ;
Petit, E ;
Sharp, FR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) :39728-39738
[6]   HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia [J].
Berra, E ;
Benizri, E ;
Ginouvès, A ;
Volmat, V ;
Roux, D ;
Pouysségur, J .
EMBO JOURNAL, 2003, 22 (16) :4082-4090
[7]   Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1 [J].
Bhattacharya, S ;
Michels, CL ;
Leung, MK ;
Arany, ZP ;
Kung, AL ;
Livingston, DM .
GENES & DEVELOPMENT, 1999, 13 (01) :64-75
[8]   Hypoxia:: the tumor's gateway to progression along the angiogenic pathway [J].
Brahimi-Horn, C ;
Berra, E ;
Pouysségur, J .
TRENDS IN CELL BIOLOGY, 2001, 11 (11) :S32-S36
[9]   Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies [J].
Brown, JM .
MOLECULAR MEDICINE TODAY, 2000, 6 (04) :157-162
[10]   Transcription - Oxygen sensing gets a second wind [J].
Bruick, RK ;
McKnight, SL .
SCIENCE, 2002, 295 (5556) :807-808